EFDID: 90265EFD: View Filing

Issuer: Bellerophon Therapeutics LLC (0001600132) - D

Accession: 0001600132-14-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001600132
  • Entity Name:
    Bellerophon Therapeutics LLC
  • Entity Type:
    Limited Liability Company
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2014)
  • Address:
    53 FRONTAGE ROAD
    Third Floor
    HAMPTON, NJ 08827
  • Persons:
    Related Persons 12
    Daniel Tasse
    Executive OfficerDirector
    Manesh Naidu
    Executive Officer
    Martin Meglasson
    Executive Officer
    Reinilde Heyrman
    Executive Officer
    David Abrams
    Executive Officer
    Aldo Belloni
    Director
    Matthew Holt
    Director
    Andre Moura
    Director
    Robert Nelsen
    Director
    Howard Pien
    Director
    Bryan Roberts
    Director
    Adam Weinstein
    Director
EDGAR: Offering Information
  • Accession Date:
    02/21/2014
  • First Sale Date:
    02/10/2014
  • Offering Amount:
    $1
  • Amount Sold:
    $1
  • Exemptions:
    Rule 506
  • Security Type(s):
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Bellerophon Therapeutics LLC/s/ David AbramsDavid AbramsTreasurer2014-02-20